Twelve-year survival after multiple recurrences and repeated metastasectomies for renal cell Carcinoma

World Journal of Surgical Oncology

Volumn 9, Issue , 2011, Pages

  Wang, Jue ^a   Talmon, Geoffrey A ^a   Feloney, Michael ^a   Morris, Michael C ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Metastasectomy; Metastatic disease; Recurrence; Renal cell carcinoma (rcc)

Indexed keywords

ADRENAL TUMOR; ADRENALECTOMY; ADULT; ARTICLE; CANCER SURVIVAL; CASE REPORT; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; METASTASIS; NEPHRECTOMY; PANCREAS RESECTION; PANCREAS TUMOR; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; KIDNEY TUMOR; METASTASIS RESECTION; MIDDLE AGED; MORTALITY; PATHOLOGY;

CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; METASTASECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 82155203007     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-9-155     Document Type: Article

References (17)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60(5):277-300. 10.3322/caac.20073, 20610543.
2. Chow WH, Devesa SS, Warren JL, Fraumeni JF. Rising incidence of renal cell cancer in the United States. JAMA 1999, 281(17):1628-31. 10.1001/jama.281.17.1628, 10235157.
3. Vogelzang NJ, Scardino PT, Shipley WU, Coffey DS. Comprehensive Textbook of Genitourinary Oncology 1996, Williams & Wilkins, Baltimore, USA.
4. Flanigan RC, Campbell SC, Clark JI, Picken MM. Metastatic renal cell carcinoma. Curr Treat Options Oncol 2003, 4(5):385-90. 10.1007/s11864-003-0039-2, 12941198.
5. Hutson TE, Figlin RA, Kuhn JG, Motzer RJ. Targeted therapies for metastatic renal cell carcinoma: an overview of toxicity and dosing strategies. Oncologist 2008, 13(10):1084-96. 10.1634/theoncologist.2008-0120, 18838439.
6. Breau RH, Blute ML. Surgery for renal cell carcinoma metastases. Curr Opin Urol 2010, 20(5):375-81. 10.1097/MOU.0b013e32833c7ada, 20592612.
7. van der Poel HG, Roukema JA, Horenblas S, van Geel AN, Debruyne FM. Metastasectomy in renal cell carcinoma: A multicenter retrospective analysis. Eur Urol 1999, 35(3):197-203. 10.1159/000019849, 10072620.
8. Kavolius JP, Mastorakos DP, Pavlovich C, Russo P, Burt ME, Brady MS. Resection of metastatic renal cell carcinoma. J Clin Oncol 1998, 16:2261-6.
9. Kierney PC, van Heerden JA, Segura JW, Weaver AL. Surgeon's role in the management of solitary renal cell carcinoma metastases occurring subsequent to initial curative nephrectomy: an institutional review. Ann Surg Oncol 1994, 1:345-52. 10.1007/BF02303572, 7850534.
10. Alt AL, Boorjian SA, Lohse CM, Costello BA, Leibovich BC, Blute ML. Survival after complete surgical resection of multiple metastases from renal cell carcinoma. Cancer 2011, 117(13):2873-82. 10.1002/cncr.25836, 21692048.
11. Swanson DA. Surgery for metastases of renal cell carcinoma. Scand J Surg 2004, 93(2):150-5.
12. Sohn TA, Yeo CJ, Cameron JL, Nakeeb A, Lillemoe KD. Renal cell carcinoma metastatic to the pancreas: results of surgical management. J Gastrointest Surg 2001, 5(4):346-51. 10.1016/S1091-255X(01)80060-3, 11985973.
13. Ghavamian R, Klein KA, Stephens DH, Welch TJ, LeRoy AJ, Richardson RL, Burch PA, Zincke H. Renal cell carcinoma metastatic to the pancreas: clinical and radiological features. Mayo Clin Proc 2000, 75(6):581-5. 10.4065/75.6.581, 10852418.
14. Köpke T, Bierer S, Wülfing C, Tiemann A, Hertle L, Herrmann E. Multimodality treatment paradigms for renal cell carcinoma: surgery versus targeted agents. Expert Rev Anticancer Ther 2009, 9(6):763-71. 10.1586/era.09.37, 19496713.
15. Karam JA, Rini BI, Varella L, Garcia JA, Dreicer R, Choueiri TK, Jonasch E, Matin SF, Campbell SC, Wood CG, Tannir NM. Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma. J Urol 2011, 185(2):439-44. 10.1016/j.juro.2010.09.086, 21167518.
16. Shepard DR, Garcia JA. Toxicity associated with the long-term use of targeted therapies in patients with advanced renal cell carcinoma. Expert Rev Anticancer Ther 2009, 9(6):795-805. 10.1586/era.09.29, 19496716.
17. Ravaud A. Treatment-associated adverse event management in the advanced renal cell carcinoma patient treated with targeted therapies. Oncologist 2011, 16(Suppl 2):32-44.